Medical interventions for chronic rhinosinusitis in cystic fibrosis
Información
- DOI:
- https://doi.org/10.1002/14651858.CD012979Copiar DOI
- Base de datos:
-
- Cochrane Database of Systematic Reviews
- Versión publicada:
-
- 13 marzo 2018see what's new
- Tipo:
-
- Intervention
- Etapa:
-
- Protocol
- Grupo Editorial Cochrane:
-
Grupo Cochrane de Fibrosis quística y enfermedades genéticas
- Copyright:
-
- Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Cifras del artículo
Altmetric:
Citado por:
Autores
Contributions of authors
| Task | Author(s) responsible |
| Protocol stage: draft the protocol | All five authors. |
| Review stage: select which trials to include (2 + 1 arbiter) | Tulasi Kota Karanth and Dr KVL Karanth will independently select trials. Disagreements will be discussed with Dr BA Woodworth and Dr L Karanth. |
| Review stage: extract data from trials (2 people) | Tulasi Kota Karanth and Dr KVL Karanth will independently extract data from trials. |
| Review stage: enter data into RevMan | Tulasi Kota Karanth. |
| Review stage: carry out the analysis | Dr L Karanth, Dr KVL Karanth, Tulasi Kota Karanth. |
| Review stage: interpret the analysis | Dr L Karanth, Dr KVL Karanth, Tulasi Kota Karanth. |
| Review stage: draft the final review | All five authors. |
| Update stage: update the review | All five authors. |
Sources of support
Internal sources
-
No sources of support supplied
External sources
-
National Institutes of Health (NIH)/National Heart, Lung, and Blood Institute (1 R01 HL133006‐01), USA.
National Institutes of Health (NIH)/National Heart, Lung, and Blood Institute (1 R01 HL133006‐01)
-
National Institute for Health Research, UK.
This systematic review was supported by the National Institute for Health Research, via Cochrane Infrastructure funding to the Cochrane Cystic Fibrosis and Genetic Disorders Group.
Declarations of interest
TK: none known.
VK: none known.
BKW has received payment from Oakstone, LLC. for providing educational reviews of recent medical literature on topics of interest to general otolaryngologists and has received reimbursement for attending a conference on inner ear disorders from Med‐El Corporation.
BAW is a consultant for Olympus and Cook Medical and has grant support from the NHLBI and Cook Medical.
LK: none known
Acknowledgements
We thank the management of Kasturba Medical College, Johns Hopkins University School of Medicine, University of Alabama and Melaka Manipal Medical College for giving us the opportunity to be involved in the completion of this protocol. We also thank Nikki Jahnke from the Cochrane Cystic Fibrosis and Genetic Disorders Group for her help with this protocol.
This project was supported by the National Institute for Health Research, via Cochrane Infrastructure funding to the Cochrane Cystic Fibrosis and Genetic Disorders Group. The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the Systematic Reviews Programme, NIHR, NHS or the Department of Health.
Version history
| Published | Title | Stage | Authors | Version |
| 2022 Apr 07 | Medical interventions for chronic rhinosinusitis in cystic fibrosis | Review | Tulasi Kota Karanth, Veena Kota Laxminarayan KL Karanth, Bryan K Ward, Bradford A Woodworth, Laxminarayan Karanth | |
| 2019 Oct 23 | Medical interventions for chronic rhinosinusitis in cystic fibrosis | Review | Tulasi Kota Karanth, Veena Kota Laxminarayan KL Karanth, Bryan K Ward, Bradford A Woodworth, Laxminarayan Karanth | |
| 2018 Mar 13 | Medical interventions for chronic rhinosinusitis in cystic fibrosis | Protocol | Tulasi Kota Karanth, Veena KL Karanth, Bryan K Ward, Bradford A Woodworth, Laxminarayan Karanth | |
